SNX2112 T6305
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SNX-2112 is an orally active Hsp90 inhibitor, with a Kd of 16 nM.
CAS nr:
908112-43-6
Purity:
98%
Molecular Weight:
464,48
SMILES:
CC1(Cc2c(C(=O)C1)c(nn2c1cc(c(cc1)C(=O)N)N[C@H]1CC[C@@H](CC1)O)C(F)(F)F)C
Formula:
C23H27F3N4O3
Pathway:
Metabolism,Cytoskeletal Signaling
Target:
HSP,HSP
Since their establishment in the United States in 2008, they have been working in the field of biotechnology for more than 10 years. With the increase in product portfolio and the shift in production focus, they are now located in Taiwan.